Professor Melissa Brown
Professor

Melissa Brown

Email: 
Phone: 
+61 7 336 51609

Background

PROFESSOR MELISSA BROWN IS UNABLE TO SUPERVISE NEW STUDENTS FOR THE FORESEEABLE FUTURE DUE TO HER COMMITMENTS AS EXECUTIVE DEAN OF THE FACULTY OF SCIENCE.

BIOGRAPHY

Melissa Brown completed her PhD at the Walter and Eliza Hall Institute in Melbourne in 1993, on the structure and regulation of genes encoding colony-stimulating factor receptors in human leukaemia.

She then undertook postdoctoral training at the Imperial Cancer Research Fund (now Cancer Research UK) in London, funded firstly by an EMBO and then by an ICRF postdoctoral fellowship, working on the isolation and characterization of the first breast cancer susceptibility gene, BRCA1.

She joined The University of Queensland in 2000 as a Lecturer and is now a Professor and Executive Dean. In 2005 she undertook a six-month sabbatical at the Sir William Dunn School of Pathology at The University of Oxford.

The focus of Melissa’s research is cancer genetics, in particular understanding the transcriptional and post-transcriptional regulation of breast cancer genes and the impact of genetic variants on cancer risk and progression.

Availability

Professor Melissa Brown is:
Not available for supervision
Media expert

Fields of research

Biological Sciences Genetics Oncology and carcinogenesis

Qualifications

  • Bachelor of Science, University of Melbourne
  • Bachelor (Honours) of Science (Advanced), University of Melbourne
  • Doctor of Philosophy, University of Melbourne

Research interests

  • Regulation and function of cancer susceptibility genes

    Breast cancer is the most common cancer in women and results from abnormal expression or function of multiple tumour suppressor genes and oncogenes. Our laboratory is interested in the regulation and function of a number of breast cancer- associated genes including those encoding BRCA1, BRCA2, and a range of miRNAs. We use a wide variety of molecular and cellular techniques to study how the expression of these genes is regulated and to examine the molecular and cellular consequences of disrupting their function in breast epithelial cell-lines and the mammary gland of mouse models. Project 1: Regulation of the breast cancer susceptibility gene BRCA1 This project will involve identifying novel regulatory elements controlling the expression of the BRCA1 gene. We are especially interested in the 3�UTR of BRCA1 and miRNAs that target this region. This project will involve elucidating the structure, function and clinical relevance of functional elements in the BRCA1 3�UTR. These elements have the potential to form the basis of improved pre-symptomatic diagnostics for breast cancer. Project 2: Regulation of microRNA genes in advanced breast cancer The aim of this project is to identify and functionally characterize miRNA promoters and their downstream target genes. Particular interest will be given to miRNAs that may be susceptible to aberrant epigenetic regulation. These miRNA have the potential to be novel biomarkers for the identification and management of patients that are susceptible to advanced breast cancer. Project 3: Molecular & cellular consequences of disrupting breast cancer genes The aim of this project is to understand how changes in the regulation or function of breast cancer genes results in the development of breast cancer. This project will involve examining the effect of increasing and decreasing the expression of normal, variant and mutant forms of breast cancer genes on the expression of genes, including miRNAs, in breast epithelial cells. These molecules have the potential to be targets of novel therapeutic agents to treat breast cancer. Techniques: Bioinformatics, gene cloning and mutagenesis, mammalian cell culture and gene transfer, reporter gene assays, real-time PCR, Northern blotting, chromatin conformation assays, methylation specific DNA analysis, cell culture assays including cell proliferation and differentiation.

Search Professor Melissa Brown’s works on UQ eSpace

146 works between 1976 and 2023
All (146) Journal Article (111) Book Chapter (1) Conference Publication (34)

1 - 20 of 146 works

2023

Journal Article

HLA-B27, axial spondyloarthritis and survival

Li, Zhixiu, Khan, Mohammad Kazim, van der Linden, Sjef M., Winkens, Bjorn, Villiger, Peter M., Baumberger, Heinz, van Zandwijk, Hermine, Khan, Muhammad Asim and Brown, Matthew A. (2023). HLA-B27, axial spondyloarthritis and survival. Annals of the Rheumatic Diseases, 82 (12), 1558-1567. doi: 10.1136/ard-2023-224434

HLA-B27, axial spondyloarthritis and survival

2023

Journal Article

Why do some patients have severe sacroiliac disease but no syndesmophytes in ankylosing spondylitis? Data from a nested case-control study

Ridley, Lauren K., Hwang, Mark C., Reveille, John D., Gensler, Lianne S., Ishimori, Mariko L., Brown, Matthew A., Rahbar, Mohammad H., Tahanan, Amirali, Ward, Michael M., Weisman, Michael H. and Learch, Thomas J. (2023). Why do some patients have severe sacroiliac disease but no syndesmophytes in ankylosing spondylitis? Data from a nested case-control study. Journal of Rheumatology, 50 (3), 335-341. doi: 10.3899/jrheum.211230

Why do some patients have severe sacroiliac disease but no syndesmophytes in ankylosing spondylitis? Data from a nested case-control study

2023

Journal Article

Genetically encoded Runx3 and CD4+ intestinal epithelial lymphocyte deficiencies link SKG mouse and human predisposition to spondyloarthropathy

Bhuyan, Zaied Ahmed, Rahman, M. Arifur, Maradana, Muralidhara Rao, Mehdi, Ahmed M., Bergot, Anne-Sophie, Simone, Davide, El-Kurdi, Marya, Garrido-Mesa, Jose, Cai, Cheng Bang Benjamin, Cameron, Amy J., Hanson, Aimee L., Nel, Hendrik J., Kenna, Tony, Leo, Paul, Rehaume, Linda, Brown, Matthew A., Ciccia, Francesco and Thomas, Ranjeny (2023). Genetically encoded Runx3 and CD4+ intestinal epithelial lymphocyte deficiencies link SKG mouse and human predisposition to spondyloarthropathy. Clinical Immunology, 247 109220, 1-14. doi: 10.1016/j.clim.2022.109220

Genetically encoded Runx3 and CD4+ intestinal epithelial lymphocyte deficiencies link SKG mouse and human predisposition to spondyloarthropathy

2023

Journal Article

A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2

Zanti, Maria, O'Mahony, Denise G., Parsons, Michael T., Li, Hongyan, Dennis, Joe, Aittomäkkiki, Kristiina, Andrulis, Irene L., Anton-Culver, Hoda, Aronson, Kristan J., Augustinsson, Annelie, Becher, Heiko, Bojesen, Stig E., Bolla, Manjeet K., Brenner, Hermann, Brown, Melissa A., Buys, Saundra S., Canzian, Federico, Caputo, Sandrine M., Castelao, Jose E., Chang-Claude, Jenny, Czene, Kamila, Daly, Mary B., De Nicolo, Arcangela, Devilee, Peter, Dörk, Thilo, Dunning, Alison M., Dwek, Miriam, Eccles, Diana M., Engel, Christoph ... Michailidou, Kyriaki (2023). A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2. Human Mutation, 2023 9961341, 1-17. doi: 10.1155/2023/9961341

A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to BRCA1 and BRCA2

2022

Journal Article

Substitution mutational signatures in whole-genome-sequenced cancers in the UK population

Degasperi, Andrea, Zou, Xueqing, Amarante, Tauanne Dias, Martinez-Martinez, Andrea, Koh, Gene Ching Chiek, Dias, Joao M. L., Heskin, Laura, Chmelova, Lucia, Rinaldi, Giuseppe, Wang, Valerie Ya Wen, Nanda, Arjun S., Bernstein, Aaron, Momen, Sophie E., Young, Jamie, Perez-Gil, Daniel, Memari, Yasin, Badja, Cherif, Shooter, Scott, Czarnecki, Jan, Brown, Matthew A., Davies, Helen R. and Nik-Zainal, Serena (2022). Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. Science, 376 (6591) eabl9283, 1-17. doi: 10.1126/science.abl9283

Substitution mutational signatures in whole-genome-sequenced cancers in the UK population

2021

Journal Article

Intra-aortic balloon pump as a bridge to durable left ventricular assist device

Brown, Matthew A., Sheikh, Farooq H., Ahmed, Sara, Najjar, Samer S. and Molina, Ezequiel J. (2021). Intra-aortic balloon pump as a bridge to durable left ventricular assist device. Journal of the American Heart Association, 10 (15) e019376, 1-8. doi: 10.1161/JAHA.120.019376

Intra-aortic balloon pump as a bridge to durable left ventricular assist device

2021

Journal Article

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

Johnson, Nichola, Maguire, Sarah, Morra, Anna, Kapoor, Pooja Middha, Tomczyk, Katarzyna, Jones, Michael E., Schoemaker, Minouk J., Gilham, Clare, Bolla, Manjeet K., Wang, Qin, Dennis, Joe, Ahearn, Thomas U., Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arndt, Volker, Aronson, Kristan J., Augustinsson, Annelie, Baynes, Caroline, Freeman, Laura E. Beane, Beckmann, Matthias W., Benitez, Javier, Bermisheva, Marina, Blomqvist, Carl, Boeckx, Bram, Bogdanova, Natalia V., Bojesen, Stig E., Brauch, Hiltrud, Brenner, Hermann ... Fletcher, Olivia (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4), 842-854. doi: 10.1038/s41416-020-01185-w

CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

2020

Journal Article

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Fachal, Laura, Aschard, Hugues, Beesley, Jonathan, Barnes, Daniel R., Allen, Jamie, Kar, Siddhartha, Pooley, Karen A., Dennis, Joe, Michailidou, Kyriaki, Turman, Constance, Soucy, Penny, Lemaçon, Audrey, Lush, Michael, Tyrer, Jonathan P., Ghoussaini, Maya, Marjaneh, Mahdi Moradi, Jiang, Xia, Agata, Simona, Aittomäki, Kristiina, Alonso, M. Rosario, Andrulis, Irene L., Anton-Culver, Hoda, Antonenkova, Natalia N., Arason, Adalgeir, Arndt, Volker, Aronson, Kristan J., Arun, Banu K., Auber, Bernd, Auer, Paul L. ... Dunning, Alison M. (2020). Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1), 56-73. doi: 10.1038/s41588-019-0537-1

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

2019

Journal Article

Caution: plasmid DNA topology affects luciferase assay reproducibility and outcomes

Tudini, Emma, Burke, Lez J., Whiley, Phillip J., Sevcik, Jan, Spurdle, Amanda B. and Brown, Melissa A. (2019). Caution: plasmid DNA topology affects luciferase assay reproducibility and outcomes. BioTechniques, 67 (3), 94-96. doi: 10.2144/btn-2019-0060

Caution: plasmid DNA topology affects luciferase assay reproducibility and outcomes

2019

Journal Article

Towards controlled terminology for reporting germline cancer susceptibility variants: An ENIGMA report

Spurdle, Amanda B., Greville-Heygate, Stephanie, Antoniou, Antonis C., Brown, Melissa, Burke, Leslie, De La Hoya, Miguel, Domchek, Susan, Dörk, Thilo, Firth, Helen V., Monteiro, Alvaro N., Mensenkamp, Arjen, Parsons, Michael T., Radice, Paolo, Robson, Mark, Tischkowitz, Marc, Tudini, Emma, Turnbull, Clare, Vreeswijk, Maaike P.G., Walker, Logan C., Tavtigian, Sean and Eccles, Diana M. (2019). Towards controlled terminology for reporting germline cancer susceptibility variants: An ENIGMA report. Journal of Medical Genetics, 56 (6), 347-357. doi: 10.1136/jmedgenet-2018-105872

Towards controlled terminology for reporting germline cancer susceptibility variants: An ENIGMA report

2019

Journal Article

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer

Milevskiy, Michael J. G., Gujral, Udai, Del Lama Marques, Carolina, Stone, Andrew, Northwood, Korinne, Burke, Lez J., Gee, Julia M. W., Nephew, Kenneth, Clark, Susan and Brown, Melissa A. (2019). MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer. British Journal of Cancer, 120 (6), 621-632. doi: 10.1038/s41416-019-0395-8

MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancer

2018

Journal Article

Heritable DNA methylation marks associated with susceptibility to breast cancer

Joo, Jihoon E., Dowty, James G., Milne, Roger L., Wong, Ee Ming, Dugué, Pierre-Antoine, English, Dallas, Hopper, John L., Goldgar, David E., Giles, Graham G., Southey, Melissa C., kConFab, Sexton, Adrienne, Christian, Alice, Trainer, Alison, Spigelman, Allan, Fellows, Andrew, Shelling, Andrew, De Fazio, Anna, Blackburn, Anneke, Crook, Ashley, Meiser, Bettina, Patterson, Briony, Clarke, Christine, Saunders, Christobel, Hunt, Clare, Scott, Clare, Amor, David, Marsh, Deborah, Edkins, Edward ... Antill, Yoland (2018). Heritable DNA methylation marks associated with susceptibility to breast cancer. Nature Communications, 9 (1) 867. doi: 10.1038/s41467-018-03058-6

Heritable DNA methylation marks associated with susceptibility to breast cancer

2018

Journal Article

Non-coding variants in BRCA1 and BRCA2 genes: potential impact on breast and ovarian cancer predisposition

dos Santos, Elizabeth Santana, Lallemand, François, Burke, Leslie, Stoppa-Lyonnet, Dominique, Brown, Melissa, Caputo, Sandrine M. and Rouleau, Etienne (2018). Non-coding variants in BRCA1 and BRCA2 genes: potential impact on breast and ovarian cancer predisposition. Cancers, 10 (11) 453, 453. doi: 10.3390/cancers10110453

Non-coding variants in BRCA1 and BRCA2 genes: potential impact on breast and ovarian cancer predisposition

2018

Journal Article

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer

Milevskiy, Michael J. G., Sandhu, Gurveen K., Wronski, Anna, Korbie, Darren, Brewster, Brooke L., Shewan, Annette, Edwards, Stacey L., French, Juliet D. and Brown, Melissa A. (2018). MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer. Oncotarget, 9 (71), 33577-33588. doi: 10.18632/oncotarget.26094

MiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancer

2018

Journal Article

BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

Burke, Leslie J., Sevcik, Jan, Gambino, Gaetana, Tudini, Emma, Mucaki, Eliseos J., Shirley, Ben C., Whiley, Phillip, Parsons, Michael T., De Leeneer, Kim, Gutiérrez-Enríquez, Sara, Santamariña, Marta, Caputo, Sandrine M., Santana dos Santos, Elizabeth, Soukupova, Jana, Janatova, Marketa, Zemankova, Petra, Lhotova, Klara, Stolarova, Lenka, Borecka, Mariana, Moles-Fernández, Alejandro, Manoukian, Siranoush, Bonanni, Bernardo, Edwards, Stacey L., Blok, Marinus J., van Overeem Hansen, Thomas, Rossing, Maria, Diez, Orland, Vega, Ana, Claes, Kathleen B.M. ... ENIGMA Consortium (2018). BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding. Human Mutation, 39 (12), 2025-2039. doi: 10.1002/humu.23652

BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

2017

Journal Article

Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage

Betts, Joshua A., Moradi Marjaneh, Mahdi, Al-Ejeh, Fares, Lim, Yi Chieh, Shi, Wei, Sivakumaran, Haran, Tropee, Romain, Patch, Ann.-Marie, Clark, Michael B., Bartonicek, Nenad, Wiegmans, Adrian P., Hillman, Kristine M., Kaufmann, Susanne, Bain, Amanda L., Gloss, Brian S., Crawford, Joanna, Kazakoff, Stephen, Wani, Shivangi, Wen Shu W., Day, Bryan, Moller, Andreas, Cloonan, Nicole, Pearson,John, Brown, Melissa A., Mercer, Timothy R., Waddell, Nicola, Khanna, Kum Kum, Dray, Eloise, Dinger, Marcel E. ... French, Juliet D. (2017). Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage. American Journal of Human Genetics, 101 (2), 255-266. doi: 10.1016/j.ajhg.2017.07.007

Long noncoding RNAs CUPID1 and CUPID2 mediate breast cancer risk at 11q13 by modulating the response to DNA damage

2017

Conference Publication

RNA immunoprecipitation reveals lncRNA-protein interactions in basal-like breast cancer

Northwood, K., Saunus, J., Milevskiy, M., Lakhani, S. and Brown, M. (2017). RNA immunoprecipitation reveals lncRNA-protein interactions in basal-like breast cancer. San Antonio Breast Cancer Symposium, San Antonio TX, United States, 6-10 December 2016. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS16-P1-04-05

RNA immunoprecipitation reveals lncRNA-protein interactions in basal-like breast cancer

2016

Journal Article

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer

Milevskiy, Michael J. G., Al-Ejeh, Fares, Saunus, Jodi M., Northwood, Korinne S., Bailey, Peter J., Betts, Joshua A., McCart Reed, Amy E., Nephew, Kenneth P., Stone, Andrew, Gee, Julia M. W., Dowhan, Dennis H., Dray, Eloise, Shewan, Annette M., French, Juliet D., Edwards, Stacey L., Clark, Susan J., Lakhani, Sunil R. and Brown, Melissa A. (2016). Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer. Human Molecular Genetics, 25 (15), 3269-3283. doi: 10.1093/hmg/ddw177

Long-range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer

2016

Journal Article

The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin

Peters, Amelia A., Milevskiy, Michael J. G., Lee, WeiC., Curry, Merril C., Smart, Chanel E., Saunus, Jodi M., Reid, Lynne, da Silva, Leonard, Marcial, Daneth L., Dray, Eloise, Brown, Melissa A., Lakhani, Sunil R., Roberts-Thomson, Sarah J. and Monteith, Gregory R. (2016). The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin. Scientific Reports, 6 (1) 25505, 25505. doi: 10.1038/srep25505

The calcium pump plasma membrane Ca(2+)-ATPase 2 (PMCA2) regulates breast cancer cell proliferation and sensitivity to doxorubicin

2016

Journal Article

MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland

Wronski, A., Sandhu, G. K., Milevskiy, M. J., Brewster, B. L., Bridge, J. A., Shewan, A. M., Edwards, S. L., French, J. D. and Brown, M. A. (2016). MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland. Oncogenesis, 5 (4) e218, e218.1-e218.9. doi: 10.1038/oncsis.2016.27

MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland

Past funding

  • 2016 - 2019
    Clinical classification of regulatory variants in breast cancer susceptibility genes
    NHMRC Project Grant
    Open grant
  • 2015 - 2018
    Profiling the intratumoural microbiome and host reactions in breast cancer tissue
    Wesley Merdical Research
    Open grant
  • 2015 - 2017
    Exploiting the overexpression of a specific calcium permeable ion channel in breast cancer cells: a new pharmacological approach to targeting breast cancer.
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Making Herceptin-resistant tumours Herceptin responsive: adapting new therapeutic potential from Head and Neck Cancer research to improve breast cancer outcomes
    National Breast Cancer Foundation
    Open grant
  • 2014
    A confocal microscope for investigation of live bacterial and viral pathogens and for molecular cell biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2019
    Enabling Clinical Epigenetic Diagnostics: The Next Generation of Personalized Breast Cancer Care
    National Breast Cancer Foundation
    Open grant
  • 2013 - 2015
    Examination of the Expression and Potential Role of Cancer Associated Viral Sequences in the Causation and Outcomes of Breast Cancer Patients
    Wesley Merdical Research
    Open grant
  • 2013 - 2015
    The role of BRCA non-coding mutations in breast cancer susceptibility
    Cancer Council Queensland
    Open grant
  • 2012 - 2017
    The Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (NBCF Infrastructure Grant led by UoM)
    University of Melbourne
    Open grant
  • 2012
    An intergrated fluidic circuit system for digital PCR analysis, single-cell gene- expression, and high-throughput preparation of next-generation sequencing libraries.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2012 - 2013
    Functional analysis of breast cancer susceptibility regions
    NHMRC Project Grant
    Open grant
  • 2012 - 2015
    Transcriptional regulation of non-code RNA genes implicated in breast cancer
    Cancer Council Queensland
    Open grant
  • 2011 - 2015
    Translating health discoveries into products
    Queensland Government Smart Futures Co-Investment Fund
    Open grant
  • 2011
    Cell culture facilities for studying host-pathogen interactions and immune function
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    An integrated high -throughput fluorescence imaging facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010
    Establishment of a digital Scanscope system for virtual microscopy
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Identifying long-range regulatory elements of the breast cancer susceptibility gene, BRCA1
    NHMRC Project Grant
    Open grant
  • 2010 - 2012
    The role of the BRCA1 3'UTR in breast cancer
    Cancer Council Queensland
    Open grant
  • 2010 - 2013
    Two recently identified calcium transporters in lactation and during mammary epithelial cell apoptosis.
    NHMRC Project Grant
    Open grant
  • 2009 - 2011
    The MYB gene as a model for global transcriptional regulation: stopping, starting and looping
    ARC Discovery Projects
    Open grant
  • 2008 - 2013
    Novel strategies for prediction and control of advanced breast cancer via nanoscaled epigenetic-based biosensors
    National Breast Cancer Foundation
    Open grant
  • 2008 - 2009
    The role of the MYB oncogene in mammary carcinogenesis
    Cancer Council Queensland
    Open grant
  • 2008
    A high-throughput facility for the identification and analysis of gene regulatory elements and factors
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2009
    Investigating the role of gene loops in regulating gene expression
    ARC Discovery Projects
    Open grant
  • 2007
    Early detection of breast cancer via nanoscaled biomarker discovery and diagnostics
    National Breast Cancer Foundation
    Open grant
  • 2007 - 2009
    Noncoding RNAs as prognostic markers and therapeutic targets in breast cancer
    NHMRC Project Grant
    Open grant
  • 2006 - 2008
    Identification of new mutations that contribute to breast cancer
    NHMRC Project Grant
    Open grant
  • 2006 - 2007
    Investigating the molecular and cellular origin of BRCA-1 associated breast tumours
    National Breast Cancer Foundation
    Open grant
  • 2006 - 2007
    The role of DEP-1 as a tumour suppressor in breast cancer
    Queensland Cancer Fund
    Open grant
  • 2005 - 2006
    ESEG_The role of DEP-1 as a tumour suppressor in breast cancer
    UQ External Support Enabling Grant
    Open grant
  • 2004
    Identification Of Critical Gene Regulatory Elements Using A Combination Of Molecular Biology And Information Theory Approaches
    University of Queensland Research Development Grants Scheme
    Open grant
  • 2003 - 2004
    Investigating the Role of BRCA1 in Mammary Differentiation and Morphogenesis
    Queensland Cancer Fund
    Open grant
  • 2002 - 2003
    Investigating the role of BRCA1 in mammary differentiation and morphogenesis
    UQ Foundation Research Excellence Awards - DVC(R) Funding
    Open grant
  • 2002 - 2004
    BRCA1, PML and telomere maintenance: understanding how abnormalities in chromosome ends contribute to breast cancer
    NHMRC Project Grant
    Open grant
  • 2001 - 2002
    BRCA1 in DNA repair and tumourigenesis
    Queensland Cancer Fund
    Open grant
  • 2001 - 2003
    Identification of Critical Regulatory Elements in the BRCA1 Gene
    NHMRC Project Grant
    Open grant
  • 2001
    Understanding how molecular abnormalities contribute to breast cancer
    UQ Early Career Researcher
    Open grant
  • 2000 - 2001
    Molecular biology of the breast cancer susceptibility gene BRCA1
    UQ New Staff Research Start-Up Fund
    Open grant

Availability

Professor Melissa Brown is:
Not available for supervision

Supervision history

Completed supervision

Enquiries

Contact Professor Melissa Brown directly for media enquiries about:

  • Animal models of human diseases
  • Biology - cells
  • Biology - molecular
  • Breast cancer
  • Cancer - breast
  • Cancer - genetics
  • Cancer susceptibility genes
  • Cellular biology
  • Diseases - animal models of human diseases
  • Gene regulation
  • Genetics
  • Human diseases - animal models of
  • Molecular biology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au